This biotech stock is a bargain: Strategist
May 13, 2015 at 14:45 PM EDT
Options expert Stacey Gilbert explains why Celgene is trading at a discount to its peers.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.